"Enbucrilate" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A tissue adhesive that is applied as a monomer to moist tissue and polymerizes to form a bond. It is slowly biodegradable and used in all kinds of surgery, including dental.
| Descriptor ID |
D004659
|
| MeSH Number(s) |
D02.241.081.069.366.350 D02.626.290.350 D05.750.259.341 D25.720.259.341 D25.919.367.341 J01.637.051.720.259.341 J01.637.051.919.367.341
|
| Concept/Terms |
Enbucrilate- Enbucrilate
- Enbucrilates
- Butyl 2-Cyanacrylate
- Butyl 2 Cyanacrylate
- Butyl 2-Cyanacrylates
- NBCA compound
- NBCA compounds
- N-butyl-2-cyanoacrylate
- N butyl 2 cyanoacrylate
- N-butyl-2-cyanoacrylates
- N-butyl-cyanoacrylate
- N butyl cyanoacrylate
- N-butyl-cyanoacrylates
- 2-Cyanobutylacrylate
- 2 Cyanobutylacrylate
- 2-Cyanobutylacrylates
- Enbucrylate
- Enbucrylates
Polybutyl Cyanoacrylate- Polybutyl Cyanoacrylate
- Cyanoacrylate, Polybutyl
- Cyanoacrylates, Polybutyl
- Polybutyl Cyanoacrylates
|
Below are MeSH descriptors whose meaning is more general than "Enbucrilate".
Below are MeSH descriptors whose meaning is more specific than "Enbucrilate".
This graph shows the total number of publications written about "Enbucrilate" by people in this website by year, and whether "Enbucrilate" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2022 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Enbucrilate" by people in Profiles.
-
Musmar B, Roy JM, Salim HA, Atallah E, Tjoumakaris SI, Gooch MR, Zarzour H, Ghosh R, Schmidt RF, Rosenwasser RH, Jabbour P. Comparative efficacy and safety of N-butyl cyanoacrylate vs. Onyx in the treatment of arteriovenous malformations: a systematic review and meta-analysis. Neurosurg Rev. 2024 Nov 19; 47(1):857.
-
Nota T, Kageyama K, Yamamoto A, Jogo A, Sohgawa E, Yonezawa H, Murai K, Ogawa S, Miki Y. Feasibility of gel-like radiopaque embolic material using gelatin sponge and contrast agent for tract embolization after percutaneous treatment. PLoS One. 2023; 18(2):e0281384.
-
Satti SR, Kottenmeier E, Khaled A, Wright GWJ, Cameron HL. Economic analysis of n-butyl cyanoacrylate compared with ethylene vinyl alcohol copolymer liquid embolic embolization of brain arteriovenous malformations (bAVMs) from a US hospital perspective. Interv Neuroradiol. 2023 Aug; 29(4):434-441.
-
Smolock AR, Nadolski G, Itkin M. Intranodal Glue Embolization for the Management of Postsurgical Groin Lymphocele and Lymphorrhea. J Vasc Interv Radiol. 2018 10; 29(10):1462-1465.
-
McConnell KA, Tjoumakaris SI, Allen J, Shapiro M, Bescke T, Jabbour PM, Rosenwasser RH, Nelson PK. Neuroendovascular management of dural arteriovenous malformations. Neurosurg Clin N Am. 2009 Oct; 20(4):431-9.
-
Forsberg F, Goldberg BB, Liu JB, Merton DA, Rawool NM, Shi WT. Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma. Radiology. 1999 Jan; 210(1):125-32.
-
Rosenwasser RH, Berenstein A, Nelson PK, Setton A, Jafar JJ, Marotta T. Safety of embolic materials. J Neurosurg. 1993 Jul; 79(1):153-5.